We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bacchus Vascular has announced the recent FDA clearance of the TRELLIS-8 Peripheral
Infusion System, an advanced drug infusion catheter designed for the treatment
of deep vein thrombosis and arterial occlusions by enabling targeted delivery
of clot-dissolving drugs.
The FDA has conditionally approved an investigational device exemption for Archus
Orthopedics' Total Facet Arthroplasty System (TFAS), allowing the company to
initiate a pivotal clinical trial of the device in the U.S.
Power3 Medical Products has entered into a collaborative research agreement
with New Horizons Diagnostics for the development of antibody-based diagnostic
tests for neurodegenerative disease using the company's identified protein biomarkers.
CryoCath Technologies has received clearance from the FDA to initiate an investigational
device exemption (IDE) study for the treatment of atrial fibrillation (AF).
Clarient and Applied Imaging
announced that the two companies have reached a settlement ending the companies'
patent infringement, unfair competition and misappropriation of trade secrets
litigation.
Serologicals announced that Upstate Group, its wholly owned subsidiary, obtained
the rights from the University of California to sell the anti-ZAP-70 monoclonal
antibody for diagnostic use.
Tessera, a Seattle-based biomedical company, has released its first product,
ProstaMark EPCA (Early Prostate Cancer Antigen), as an analyte specific reagent
for commercial use in pathology laboratories to assist pathologists in their
efforts to determine if cancer is present in the prostate.
Sigma Global, a direct-to-consumer marketer of pharmaceuticals and medical devices,
announced it has acquired Global Health Services, a product development company
currently focused on its SureOne diabetic insulin syringe product line, according
to Chairman and CEO Bryan Chance.
Longport, a medical technology specialist in high resolution ultrasound imaging,
announced they have been informed of $1.7 million NIH grant application for
a three-year collaborative study of pressure ulcer development using the Longport
EPISCAN I-200.
eGene announced that it has been issued U.S. Patent No. 6,870,167 "Multi-Color
Multiplexed Analysis In a Bio-Separation System," by the U.S. Patent and
Trademark Office.
EnteroMedics, a developer of medical devices for the treatment of obesity and
gastrointestinal disorders, announced that the Mayo Foundation for Medical Education
and Research, Rochester, Minn., has entered into an exclusive collaborative
obesity device research and development agreement with the company.